We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$996M
AUM Growth
+$73M
Cap. Flow
-$4.39M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$11.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.4M
3
TFC icon
Truist Financial
TFC
+$2.17M
4
FENY icon
Fidelity MSCI Energy Index ETF
FENY
+$1.55M
5
IBM icon
IBM
IBM
+$1.33M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.06M
2
MMM icon
3M
MMM
+$6.04M
3
STI
SunTrust Banks, Inc.
STI
+$2.12M
4
STZ icon
Constellation Brands
STZ
+$1.69M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 13.59%
3 Financials 12.59%
4 Industrials 12.28%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
26
Danaher
DHR
$141B
$8.56M 0.86%
62,898
-190
-0.3% -$24K
MINT icon
27
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$8.47M 0.85%
83,427
-92
-0.1% -$9.35K
VZ icon
28
Verizon
VZ
$195B
$7.67M 0.77%
124,953
-820
-0.7% -$49.5K
BMY icon
29
Bristol-Myers Squibb
BMY
$131B
$7.25M 0.73%
112,965
+59,360
+111% +$3.4M
BLK icon
30
Blackrock
BLK
$175B
$6.95M 0.7%
13,817
-102
-0.7% -$48.4K
PEP icon
31
PepsiCo
PEP
$189B
$6.79M 0.68%
49,647
-597
-1% -$81.2K
CSCO icon
32
Cisco
CSCO
$476B
$6.73M 0.68%
140,278
+2,701
+2% +$126K
V icon
33
Visa
V
$692B
$6.49M 0.65%
34,532
+805
+2% +$145K
RTX icon
34
RTX Corp
RTX
$301B
$6.38M 0.64%
67,736
-159
-0.2% -$14.4K
ABBV icon
35
AbbVie
ABBV
$431B
$6.36M 0.64%
71,827
-209
-0.3% -$17.4K
PFE icon
36
Pfizer
PFE
$149B
$6.31M 0.63%
169,698
-4,802
-3% -$171K
NKE icon
37
Nike
NKE
$62.3B
$6.25M 0.63%
61,714
-512
-0.8% -$48.3K
MA icon
38
Mastercard
MA
$505B
$6.17M 0.62%
20,646
-629
-3% -$177K
VEA icon
39
Vanguard FTSE Developed Markets ETF
VEA
$234B
$6.15M 0.62%
139,541
+1,191
+0.9% +$50.8K
CRM icon
40
Salesforce
CRM
$153B
$6.13M 0.62%
37,700
-155
-0.4% -$24.3K
ORCL icon
41
Oracle
ORCL
$413B
$5.73M 0.58%
108,149
-1,436
-1% -$79K
ROP icon
42
Roper Technologies
ROP
$39.3B
$5.66M 0.57%
15,963
+808
+5% +$279K
VCSH icon
43
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$5.57M 0.56%
68,709
+74
+0.1% +$6K
CAT icon
44
Caterpillar
CAT
$394B
$5.4M 0.54%
36,543
+67
+0.2% +$9.35K
AMGN icon
45
Amgen
AMGN
$219B
$5.22M 0.52%
21,646
+98
+0.5% +$21.6K
T icon
46
AT&T
T
$162B
$4.96M 0.5%
168,192
+1,115
+0.7% +$32.2K
ADP icon
47
Automatic Data Processing
ADP
$109B
$4.91M 0.49%
28,816
-94
-0.3% -$15.6K
ACN icon
48
Accenture
ACN
$105B
$4.8M 0.48%
22,821
-451
-2% -$87.9K
VWO icon
49
Vanguard FTSE Emerging Markets ETF
VWO
$123B
$4.71M 0.47%
105,829
+920
+0.9% +$39K
VCIT icon
50
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$4.52M 0.45%
49,543
+304
+0.6% +$27.7K
1
2
3 4 5

Similar funds

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15.01% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Parsons Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
  • Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
  • Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
  • Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
  • Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
  • Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
  • Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.